Catalyst Wire Dossier Catalyst Wire Dossier

Ceftolozane/tazobactam (Zerbaxa)

ceftolozane/tazobactam · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ceftolozane/tazobactam (Zerbaxa), covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036) [Phase 1]

See pricing